Available Preparations In the UK, several GLP-1 receptor agonists are licensed and available through the NHS, including: Semaglutide (Ozempic, Wegovy, and oral Rybelsus) Dulaglutide (Trulicity) Liraglutide (Victoza, Saxenda) Exenatide (Byetta, Bydureon) Lixisenatide (Lyxumia) Most are administered via subcutaneous injection, with dosing frequencies ranging from twice daily to once weekly, depending on the specific formulation
In other words, significant weight loss happened with semaglutide
They are prepared by licensed compounding pharmacies using ingredients from FDA-regulated suppliers
For many patients, GLP-1s are excellent toolsbut they are not the only tools
It uses the same semaglutide molecule as Rybelsus but at a significantly higher dose, and carries approval for obesity treatment and cardiovascular risk reduction in adults with overweight or obesity and established cardiovascular disease
The choice between semaglutide and tirzepatide depends on your health history, metabolic profile, treatment goals, and how your body responds